Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie L Graff

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Therapeutic Advances in Medical Oncology|April 29, 2025
TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancerPeter Schmid, Mafalda Oliveira, Joyce O'Shaughnessy, et al.
The Oncologist|March 26, 2025
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitisFunda Meric-Bernstam, Aditya Bardia, Paolo Bossi, et al.
JCO Oncology Practice|September 19, 2024
Investigating the Salience of Clinical Meaningfulness and Clinically Meaningful Outcomes in Metastatic Breast Cancer Care DeliveryStephanie L Graff, Emily C Freeman, Meaghan Roach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 12, 2019
Evaluating Unconscious Bias: Speaker Introductions at an International Oncology ConferenceNarjust Duma, Urshila Durani, Cynthia B Woods, et al.
Breast Cancer Research and Treatment|September 20, 2024
Genomic and transcriptomic landscape of HER2-low breast cancerRani Bansal, Tolulope Adeyelu, Andrew Elliott, et al.
Cancers|April 27, 2024
The Genomic, Transcriptomic, and Immunologic Landscape of <i>HRAS</i> Mutations in Solid TumorsSamuel A Kareff, Asaad Trabolsi, Harris B Krause, et al.
JCO Oncology Practice|March 21, 2022
Social Media and Professional Development for Oncology ProfessionalsAnusha Chidharla, Audun Utengen, Deanna J Attai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2018
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused UpdateNeelima Denduluri, Mariana Chavez-MacGregor, Melinda L Telli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 1, 2024
Joint EANM-SNMMI guidelines on the role of 2-[<sup>18</sup>F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelinesDavid Groheux, Sofia C Vaz, Gary A Ulaner, et al.
Breast (Edinburgh, Scotland)|September 20, 2024
Role of [<sup>18</sup>F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelinesDavid Groheux, Sofia C Vaz, Philip Poortmans, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Therapeutic Advances in Medical Oncology|April 29, 2025
TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancerPeter Schmid, Mafalda Oliveira, Joyce O'Shaughnessy, et al.
The Oncologist|March 26, 2025
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitisFunda Meric-Bernstam, Aditya Bardia, Paolo Bossi, et al.
JCO Oncology Practice|September 19, 2024
Investigating the Salience of Clinical Meaningfulness and Clinically Meaningful Outcomes in Metastatic Breast Cancer Care DeliveryStephanie L Graff, Emily C Freeman, Meaghan Roach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 12, 2019
Evaluating Unconscious Bias: Speaker Introductions at an International Oncology ConferenceNarjust Duma, Urshila Durani, Cynthia B Woods, et al.
Breast Cancer Research and Treatment|September 20, 2024
Genomic and transcriptomic landscape of HER2-low breast cancerRani Bansal, Tolulope Adeyelu, Andrew Elliott, et al.
Cancers|April 27, 2024
The Genomic, Transcriptomic, and Immunologic Landscape of <i>HRAS</i> Mutations in Solid TumorsSamuel A Kareff, Asaad Trabolsi, Harris B Krause, et al.
JCO Oncology Practice|March 21, 2022
Social Media and Professional Development for Oncology ProfessionalsAnusha Chidharla, Audun Utengen, Deanna J Attai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2018
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused UpdateNeelima Denduluri, Mariana Chavez-MacGregor, Melinda L Telli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 1, 2024
Joint EANM-SNMMI guidelines on the role of 2-[<sup>18</sup>F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelinesDavid Groheux, Sofia C Vaz, Gary A Ulaner, et al.
Breast (Edinburgh, Scotland)|September 20, 2024
Role of [<sup>18</sup>F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelinesDavid Groheux, Sofia C Vaz, Philip Poortmans, et al.
Pageof 7